Entyvio (vedolizumab) - Takeda
Entyvio: Regulatory approval in Japan for Crohn's disease in H1 FY2019 (Takeda) - May 15, 2019 - FY 2018 Results 
Japanese regulatory
https://www.takeda.com/investors/reports/quarterly-announcements/quarterly-announcements-2018/
 
May 15, 2019
 
 
2a38cd79-1c8c-4316-aa4d-71871daa6b92.jpg